Addiction Medicine Charge Validation Software

Charge Validation in a Addiction Medicine Practice

Most addiction denials start with a charge that looked fine but broke a rule. Drug testing draws the closest review. For Medicare in Novitas states, a standing order for every patient is not covered. Definitive tests must be ordered for the patient's own history and risk. A long-acting buprenorphine injection may be covered only for opioid use disorder, so the line needs an OUD diagnosis, not a pain code. OTP intake, assessments and extra counseling given by video or phone need modifier 95 or 93. A definitive test billed by a lab that holds only a certificate of waiver won't be paid. Addiction medicine charge validation software runs these checks at checkout. A line that fails is held with the reason and the rule, so staff fix the charge or add the missing note before the claim is built.

Why Is Charge Validation Different in Addiction Medicine?

Drug testing gets more scrutiny than almost any other service in the specialty. Payers watch for blanket orders, large definitive panels run on everyone, and presumptive tests billed too often. A program can test the right patients for the right reasons and still lose the claim if the order and the note don't show why each test was needed.

Medication lines carry diagnosis and product rules. Some commercial plans cover long-acting buprenorphine only for moderate to severe OUD. They treat its use for pain as not needed. Some state Medicaid programs also ask for buprenorphine to be billed by the tablet strength dispensed, not the dose taken. These details sit in policy documents, not in the code book.

Telehealth and setting rules add another layer. OTP add-ons need the modifier that matches video or audio-only care. Intensive outpatient at an OTP isn't paid when given remotely. A charge can pass coding edits and still fail on how or where care was given. Charge validation has to read the visit details, not just the codes.

What Addiction Medicine Charge Validation Software Handles

No routine standing orders (Novitas LCD L35006)

For Medicare under Novitas, routine standing orders for all patients in a practice are not reasonable and necessary. Charge validation holds test lines that trace back to a blanket order and asks for a patient-specific order. (CMS Medicare Coverage Database, LCD L35006: Controlled Substance Monitoring and Drugs of Abuse Testing (Novitas))

Definitive testing rationale

The same LCD says definitive orders should be individualized by clinical history and risk, and the clinician's reason must be documented. Definitive lines without a linked reason are held for the ordering clinician. (CMS Medicare Coverage Database, LCD L35006: Controlled Substance Monitoring and Drugs of Abuse Testing (Novitas))

Presumptive frequency in SUD treatment

The LCD treats more than three presumptive panels in one week as not reasonable and necessary. Validation counts each patient's presumptive tests in the week before releasing another line. (CMS Medicare Coverage Database, LCD L35006: Controlled Substance Monitoring and Drugs of Abuse Testing (Novitas))

Lab certificate for definitive codes (G0480 to G0483)

Definitive codes are subject to CLIA edits, and a lab with only a certificate of waiver can't be paid for them. Validation checks the certificate type on file for the performing lab. (CMS Transmittal R3439CP (CR 9502): HCPCS codes subject to CLIA edits, including G0480 to G0483)

Telehealth modifiers on OTP add-ons (95, 93)

For dates of service on or after May 12, 2023, CMS expects modifier 95 or 93 on G2076, G2077 and G2080 when given by video or audio-only. Validation compares the visit modality with the modifier on each line. (CMS: Opioid Treatment Program (OTP) Billing & Payment)

OUD diagnosis on extended-release buprenorphine

UnitedHealthcare's commercial policy covers Brixadi and Sublocade for opioid use disorder and calls use for pain management unproven and not medically necessary. Validation checks that an F11.2 diagnosis supports the injection line. (UnitedHealthcare Commercial Medical Benefit Drug Policy: Buprenorphine (Brixadi and Sublocade), effective October 1, 2026)

Tablet strength billing (Washington Medicaid)

Washington Apple Health asks OTPs to bill buprenorphine products by the tablet strength dispensed, not the dose given. Validation checks the NDC and quantity against that rule for Washington claims. (Washington Apple Health (Medicaid) Substance Use Disorder Billing Guide, October 2025)

How Does Addiction Medicine Charge Validation Software Work?

1. 1. Receive assembled lines

   Lines arrive from addiction medicine charge assembly with codes, units, modifiers and links to the order and note.

2. 2. Run payer and coverage edits

   NCCI edits, payer policies and local coverage rules are applied to each line. Drug testing lines are checked for order type, frequency and documented reason.

3. 3. Check how and where care was given

   The visit's modality and place of service are compared with the modifiers on the line. Remote OTP intensive outpatient lines are stopped, since Medicare won't pay them.

4. 4. Confirm drugs and diagnoses

   Injection lines are checked for a supporting OUD diagnosis, the right product code and units. State rules, such as billing by tablet strength, are applied where they exist.

5. 5. Hold, explain and release

   Failed lines are held with the rule that failed and who needs to act. Fixed lines move on, and repeat failures feed denial prevention.

Addiction Medicine Charge Validation Software vs. Generic Software

Who Uses It in a Addiction Medicine Practice

• Compliance officer: Drug testing and injection lines checked against written policy before any claim leaves, with a record of each hold.
• Ordering clinician: A short note when a test or injection line needs a reason or a diagnosis, instead of a denial weeks later.
• Lab manager: Clear flags when a test is billed above what the lab's CLIA certificate allows, so testing and CLIA status stay in step.